Gaithersburg, Maryland’s Novavax has skyrocketed to national and global prominence during the coronavirus pandemic. In an incredibly short time, the company has advanced its SARS-CoV-2 vaccine candidate into Phase III trials and received FDA fast track designation, putting its vaccine very close to potential FDA approval.
Novavax is Building a Global Tech Transfer Team to Rapidly Deliver 2 Billion COVID-19 Vaccine Doses Around the World



